首页> 外文期刊>Neurological Research >Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1G93A G1H transgenic mouse model of amyotrophic lateral sclerosis
【24h】

Increased number and differentiation of neural precursor cells in the brainstem of superoxide dismutase 1G93A G1H transgenic mouse model of amyotrophic lateral sclerosis

机译:超氧化物歧化酶1 G93A G1H 转基因小鼠肌萎缩性侧索硬化的脑干中神经前体细胞数量增加和分化

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The superoxide dismutase 1G93A G1H (SOD1G93A G1H) transgenic mouse is a model of familial human amyotrophic lateral sclerosis (ALS) that has progressive neurodegeneration within the spinal cord and brainstem. In this study, we investigated the number and differentiation of neural precursor cells (NPCs). Nestin-positive NPCs were rarely seen in the nervous system of wild type controls or pre-disease mice at post-natal days 30 and 60. With disease onset on post-natal day 90, nestin labeled NPCs proliferated preferentially in the brainstem with maximal number and density at post-natal day 120. NPCs did not double-label with CNPase or O4 markers of oligodendrocytes. The majority of the NPCs co-labeled with the astrocyte maker glial fibrillary acidic protein (GFAP) and a small number with the neuronal marker NeuN. At disease onset, 73 and 10% of NPCs co-expressed GFAP and NeuN respectively while at severe disease stage, 80 and 8% of the NPCs co-expressed GFAP and NeuN. Proliferating cell nuclear antigen (PCNA) was used to confirm that at least some of these cells undergo mitosis. Future studies could be directed at controlling the differentiation of these endogenous NPCs into neurons and astrocytes in order to ameliorate the degeneration within the brainstem of the ALS mouse.
机译:超氧化物歧化酶1 G93A G1H (SOD1 G93A G1H )转基因小鼠是家族性人类肌萎缩性侧索硬化症(ALS)的模型,在脊髓和脑干内具有进行性神经变性。在这项研究中,我们调查了神经前体细胞(NPC)的数量和分化。出生后第30和60天,野生型对照或疾病前小鼠的神经系统很少见Nestin阳性NPC。出生后第90天发病时,巢蛋白标记的NPC优先在脑干中增殖,数量最多。和出生后第120天的密度。NPC未使用少突胶质细胞的CNPase或O 4 标记进行双重标记。大多数NPC与星形胶质细胞制造商的神经胶质纤维酸性蛋白(GFAP)共同标记,少数与神经元标记NeuN共同标记。在疾病发作时,分别有73%和10%的NPC共表达GFAP和NeuN,而在严重疾病阶段,分别有80%和8%的NPC共表达GFAP和NeuN。增殖细胞核抗原(PCNA)用于确认至少其中一些细胞发生有丝分裂。未来的研究可能旨在控制这些内源性NPC向神经元和星形胶质细胞的分化,以改善ALS小鼠脑干内的变性。

著录项

  • 来源
    《Neurological Research》 |2007年第2期|204-209|共6页
  • 作者单位

    Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin 300192, China;

    Department of Laboratory Medicine, Tianjin First Central Hospital, Tianjin 300192, China Motor Neuron Disease Research Laboratory, Brain Injury and Repair Group, Howard Florey Institute, The University of Melbourne, Parkville, Victoria 3010, Aus;

    Motor Neuron Disease Research Laboratory, Brain Injury and Repair Group, Howard Florey Institute, The University of Melbourne, Parkville, Victoria 3010, Australia;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号